News & Updates

Show Multimedia Only

Preconception C. trachomatis seropositivity may up risk of miscarriage

16 Jun 2025

Among women with a history of pregnancy loss, prior exposure to Chlamydia trachomatis poses an increased risk of miscarriage, as reported in a study.

Preconception C. trachomatis seropositivity may up risk of miscarriage

16 Jun 2025

Targeted-release budesonide formulation makes good in IgAN regardless of baseline eGFR

15 Jun 2025 by

Treatment with targeted-release budesonide formulation preserves kidney function and reduces proteinuria in patients with IgA nephropathy (IgAN) independent of baseline eGFR, and this benefit is seen both after 9 months of treatment and throughout the remaining 15-month off-treatment period, according to a subanalysis of the phase III NeflgArd study presented at the ERA annual meeting.

Targeted-release budesonide formulation makes good in IgAN regardless of baseline eGFR

15 Jun 2025

Probiotic supplement may improve cognition, mood in older adults

15 Jun 2025

Supplementation with probiotics appears to induce an acute effect on reaction times during executive function, hinting at the possibility of preventing the development of depression among older adults, according to a study.

Probiotic supplement may improve cognition, mood in older adults

15 Jun 2025

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness

15 Jun 2025

Treatment with steady-state, low-dose morphine does not appear to improve sleep efficiency, sleep-disordered breathing frequency, or next-day alertness but may rather result in hypoventilation during sleep in chronic obstructive pulmonary disease (COPD) patients with chronic breathlessness, according to the results of a randomized, double-anonymized, crossover trial.

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness

15 Jun 2025

Final VEDOKIDS data: Remission with maintenance vedolizumab durable in UC, less so in CD

14 Jun 2025 by

Maintenance treatment with vedolizumab proved safe and effective in paediatric inflammatory bowel disease (IBD), with long-term remission achieved more frequently in children with ulcerative colitis (UC) than in those with Crohn’s disease (CD), according to the final 3-year data from the VEDOKIDS study.

Final VEDOKIDS data: Remission with maintenance vedolizumab durable in UC, less so in CD

14 Jun 2025

Insulinemic lifestyle pattern ups risk of endometrial cancer

14 Jun 2025

A lifestyle pattern with higher insulinemic potential may predispose an individual to endometrial cancer (EC), suggests a study.

Insulinemic lifestyle pattern ups risk of endometrial cancer

14 Jun 2025

Chemo-free triplet regimen shows antitumour activity in HR+, HER2+ breast cancer

14 Jun 2025

Treatment with the combination of zanidatamab plus palbociclib and fulvestrant is safe and demonstrates promising antitumour activity in patients with HR-positive, HER2-positive advanced or metastatic breast cancer, according to a phase IIa study.

Chemo-free triplet regimen shows antitumour activity in HR+, HER2+ breast cancer

14 Jun 2025

IBD tied to increased risk of rheumatoid arthritis

13 Jun 2025

Patients with inflammatory bowel disease (IBD) appear to be at heightened risk of rheumatoid arthritis (RA), as reported in a study.

IBD tied to increased risk of rheumatoid arthritis

13 Jun 2025

Functional abdominal pain in kids: Drotaverine, peppermint oil similar in head-to-head trial

13 Jun 2025 by

Both drotaverine and peppermint oil are safe and help alleviate abdominal pain in children whose pain cannot be attributed to a specific medical condition, with neither treatment demonstrating clear superiority over the other, according to the results of a single-blind, randomized controlled trial.

Functional abdominal pain in kids: Drotaverine, peppermint oil similar in head-to-head trial

13 Jun 2025

Ultrasensitive ctDNA detection predicts breast cancer relapse

13 Jun 2025 by

A molecular residual disease (MRD) assay powered by whole genome sequencing (WGS) successfully detects breast cancer relapse, improving lead times for circulating tumour DNA (ctDNA) detection years ahead of clinical recurrence based on imaging.

Ultrasensitive ctDNA detection predicts breast cancer relapse

13 Jun 2025

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Preconception C. trachomatis seropositivity may up risk of miscarriage

Preconception C. trachomatis seropositivity may up risk of miscarriage

Targeted-release budesonide formulation makes good in IgAN regardless of baseline eGFR

Targeted-release budesonide formulation makes good in IgAN regardless of baseline eGFR

Probiotic supplement may improve cognition, mood in older adults

Probiotic supplement may improve cognition, mood in older adults

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness

Low-dose morphine may do more harm than good for COPD patients with chronic breathlessness

Final VEDOKIDS data: Remission with maintenance vedolizumab durable in UC, less so in CD

Final VEDOKIDS data: Remission with maintenance vedolizumab durable in UC, less so in CD

Insulinemic lifestyle pattern ups risk of endometrial cancer

Insulinemic lifestyle pattern ups risk of endometrial cancer

Chemo-free triplet regimen shows antitumour activity in HR+, HER2+ breast cancer

Chemo-free triplet regimen shows antitumour activity in HR+, HER2+ breast cancer

IBD tied to increased risk of rheumatoid arthritis

IBD tied to increased risk of rheumatoid arthritis

Functional abdominal pain in kids: Drotaverine, peppermint oil similar in head-to-head trial

Functional abdominal pain in kids: Drotaverine, peppermint oil similar in head-to-head trial

Ultrasensitive ctDNA detection predicts breast cancer relapse

Ultrasensitive ctDNA detection predicts breast cancer relapse